Oxantra 450 contains Oxcarbazepine 450 mg in a Sustained Release (SR) tablet designed for extended therapeutic action. Oxcarbazepine is a well-tolerated anticonvulsant widely used for controlling partial seizures and epilepsy in adults and children (as prescribed).

The sustained release technology ensures a slow, consistent release of the drug, helping prevent fluctuations in blood levels and offering better seizure control with fewer daily doses.

Indications / Uses

Oxantra 450 is commonly used for:

• Partial-onset seizures

• Secondary generalized seizures

• Epilepsy management (monotherapy or adjunct therapy)

• Neuropathic pain (off-label, physician supervised)

Key Benefits

• Sustained Release formulation for consistent therapeutic effect

• Stabilizes overactive neurons

• Reduces frequency and severity of seizures

• Improves patient adherence with reduced dosing frequency

• Better tolerability compared to older antiepileptics

• Suitable for long-term epilepsy management

How It Works

Oxcarbazepine blocks voltage-sensitive sodium channels, reducing excessive neuronal firing and stabilizing electrical activity in the brain. The SR formulation ensures prolonged drug release, maintaining steady plasma concentration over an extended period.